Gracell Biotechnologies Inc.

NASDAQ GRCL

Data sourced from iex and EODHD
Download Data

Gracell Biotechnologies Inc. Income Statement 2017 - 2023

This table shows the Income Statement for Gracell Biotechnologies Inc. going from 2017 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-06-30 2019-03-31 2018-12-31 2018-06-30 2018-03-31 2017-12-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - -
Cost of Revenue
M - - - - - - - - - - - - - - - - - - - - - -
Gross Profit
M - - - - - 0 0 0 0 - - - - - - - - - - - - -
Operating Expenses
M - - - - - 131 131 131 131 - - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 141 146 138 133 129 136 137 130 123 88 65 46 29 27 27 28 23 19 15 8 5 3
Research and Development (R&D) Expenses
M 420 463 477 471 466 421 369 322 275 227 202 169 146 136 125 127 102 86 69 39 26 13
Other Operating Expenses
M - - - - - 0 0 0 0 - - - - - - - - - - - - -
Costs and Expenses
M - - - - - - - - - - - - - - - - - - - - - -
Operating Income
M -562 -610 -614 -605 -595 -556 -506 -452 -398 -315 -267 -214 -175 -163 -152 -156 -126 -105 -84 -47 -31 -16
Interest Expense
M 7 7 7 7 6 5 5 5 4 4 3 2 1 1 0 - - - - - - -
Non-operating Income/Expense
M 73 26 35 25 15 17 17 10 4 2 4 2 1 1 -2 -4 -6 -5 -3 -1 -1 0
EBT
M -476 -580 -580 -577 -575 -533 -483 -438 -393 -314 -264 -212 -171 -155 -144 -147 -119 -100 -80 -46 -30 -15
Income Tax Provision
M 0 0 -1 -13 -26 -28 -27 -20 -13 -11 -11 -7 -8 -8 -8 -7 - - - - - -
Income after Tax
M -476 -581 -579 -564 -550 -505 -456 -418 -379 -303 -252 -205 -163 -112 -67 -36 - - - - - -
Non-Controlling Interest
M -163 0 0 0 0 0 0 2 18 18 36 44 39 39 21 11 - - - - - -
Net Income
M -334 -303 -449 -608 -605 -563 -513 -454 -425 -296 -263 -206 -159 -159 -96 -53 - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 71,894,555.75 67,834,123.25 67,684,322.25 67,204,753.50 66,725,184.75 66,629,177.50 66,519,740.75 65,300,831.75 64,081,922.75 63,647,992.00 51,791,880.50 41,519,698.25 31,247,516.00 24,098,352.50 28,387,750.00 32,677,147.50 36,966,545.00 36,966,545.00 36,966,545.00 36,966,545.00 36,966,545.00 36,966,545.00
EBITDA
M -504 -559 -566 -563 -561 -524 -477 -431 -386 -306 -257 -207 -175 -162 -152 -156 -121 -100 -80 -45 -30 -15
Depreciation and Amortization
M 58 51 49 42 35 33 30 27 24 21 22 14 6 6 5 5 5 4 4 2 1 1
EBIT
M -562 -610 -614 -605 -596 -557 -507 -458 -410 -327 -279 -220 -180 -169 -157 -161 -126 -105 -84 -47 -31 -16
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% -0.01 -0.05 0.15 2.55 4.95 5.36 5.24 4.53 3.82 3.25 3.45 2.51 4.74 6.59 9.32 15.64 - - - - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - -
Gross Profit Margin
% - - - - - 100.00 100.00 100.00 100.00 - - - - - - - - - - - - -
Operating Income Margin
% - - - - - -35,822.95 -35,822.95 -35,822.95 -35,822.95 - - - - - - - - - - - - -
Net Income Margin
% - - - - - -35,323.77 -35,323.77 -35,323.77 -35,323.77 - - - - - - - - - - - - -
EBITDA Ratio
% - - - - - -34,807.10 -34,807.10 -34,807.10 -34,807.10 - - - - - - - - - - - - -
EBIT Ratio
% - - - - - -35,822.95 -35,822.95 -35,822.95 -35,822.95 - - - - - - - - - - - - -
EBT Ratio
% - - - - - -35,323.77 -35,323.77 -35,323.77 -35,323.77 - - - - - - - - - - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email